Ratner BioMedical Inc. (RBI) is a regenerative medicine company. We apply translational research methods to tissue engineering technologies showing great promise.  Our goal is to take these new technologies to the clinic and advance the standard of care for applicable indications in the process.

Principal scientists are:
+  Dr. Buddy Ratner, University of Washington
+  Dr. Ahmet Hoke, Johns Hopkins University
+  Dr. Hai-Quan Mao, Johns Hopkins University
+  Dr. Kam Leong, Duke University

Executive Leadership: 
+  Stephen Quinn, CEO
+  Christopher Somogyi, Chairman of the Board

RBI supports TERMIS NA 2008

To inquire about our company, please email .